0
Skip to Content
RUNX1 Research Program
RUNX1 Research Program
For Patients
For Researchers
For Clinicians
Take Action
About RRP
English
DONATE
RUNX1 Research Program
RUNX1 Research Program
For Patients
For Researchers
For Clinicians
Take Action
About RRP
English
DONATE
Folder: For Patients
Back
Folder: For Researchers
Back
Folder: For Clinicians
Back
Folder: Take Action
Back
Folder: About RRP
Back
English
Back
DONATE
  • Medical Education Webinars,
  • Patient Videos & Webinars,
• 8/7/24

2021 RUNX1 Week Keynote Speaker: Dr. David Fajgenbaum

Dr. David Fajgenbaum, co-founder and CEO of the Castleman Disease Collaborative Network, discusses his personal battle with this rare disease that almost killed him several times, and his tireless research that led to the discovery of a life-saving treatment for himself and many other Castleman patients.

Previous

Crosstalk Between Transcription Factors, Methyltransferases and Tyrosine Kinases

Next

Inherited Thrombocytopenia (ITP): What Is It, Whom To Test and How To Test?

You Might Also Like

Related Embedded Video Item Thumbnail Part 2: April 2025 Sirolimus Study Update Patient Participants Perspectives and Q&A
Related Embedded Video Item Thumbnail Transferring your REDCap RUNX1 Patient Data Hub Account to Matrix
Related Embedded Video Item Thumbnail Module 3: The Potential Promise and Current Challenges of Gene Editing
Related Embedded Video Item Thumbnail On a Journey Toward a Cure - May 1st RRP Community Workshop
Related Embedded Video Item Thumbnail Mutation-Specific Epigenetic Reprogramming of Hematopoietic Stem Cells in AML

Sign Up For Our Monthly Newsletter!

Stay In Touch

Email RRP

Newsletter

Policies

Privacy Policy

Cookie Policy

Accessibility Statement

Site Resources

News & Updates

Calendar of Events

RRP Blog

DONATE
SHOP